These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 1932369)

  • 1. Human recombinant granulocyte-macrophage colony-stimulating factor augments viability and cytotoxic activities of human monocyte-derived macrophages in long-term cultures.
    Robin G; Markovich S; Athamna A; Keisari Y
    Lymphokine Cytokine Res; 1991 Aug; 10(4):257-63. PubMed ID: 1932369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of human recombinant granulocyte-macrophage colony-stimulating factor and IL-3 on the expression of surface markers of human monocyte-derived macrophages in long-term cultures.
    Dimri R; Nissimov L; Keisari Y
    Lymphokine Cytokine Res; 1994 Aug; 13(4):239-45. PubMed ID: 7528061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effect of recombinant granulocyte macrophage colony-stimulating factor on human monocytes and alveolar macrophages.
    Thomassen MJ; Barna BP; Rankin D; Wiedemann HP; Ahmad M
    Cancer Res; 1989 Aug; 49(15):4086-9. PubMed ID: 2545332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effects of IL-3, granulocyte-macrophage colony-stimulating factor, and macrophage colony-stimulating factor in supporting monocyte differentiation in culture. Analysis of macrophage antibody-dependent cellular cytotoxicity.
    Young DA; Lowe LD; Clark SC
    J Immunol; 1990 Jul; 145(2):607-15. PubMed ID: 2142182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activities of granulocyte-macrophage colony-stimulating factor and interleukin-3 on monocytes.
    Suzuki H; Katayama N; Ikuta Y; Mukai K; Fujieda A; Mitani H; Araki H; Miyashita H; Hoshino N; Nishikawa H; Nishii K; Minami N; Shiku H
    Am J Hematol; 2004 Apr; 75(4):179-89. PubMed ID: 15054806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stem cell factor augments tumor necrosis factor-granulocyte-macrophage colony-stimulating factor-mediated dendritic cell hematopoiesis.
    Santiago-Schwarz F; Rappa DA; Laky K; Carsons SE
    Stem Cells; 1995 Mar; 13(2):186-97. PubMed ID: 7540472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of human monocyte functions by tumor necrosis factor: rapid priming for enhanced release of superoxide and erythrophagocytosis, but no direct triggering of superoxide release.
    Kitagawa S; Yuo A; Yagisawa M; Azuma E; Yoshida M; Furukawa Y; Takahashi M; Masuyama J; Takaku F
    Exp Hematol; 1996 Mar; 24(4):559-67. PubMed ID: 8608807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant granulocyte-macrophage colony-stimulating factor down-regulates expression of IL-2 receptor on human mononuclear phagocytes by induction of prostaglandin E.
    Hancock WW; Pleau ME; Kobzik L
    J Immunol; 1988 May; 140(9):3021-5. PubMed ID: 3129507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of recombinant human colony stimulating factors (CSF) (granulocyte-macrophage CSF, granulocyte CSF, and CSF-1) on human monocyte/macrophage differentiation.
    Geissler K; Harrington M; Srivastava C; Leemhuis T; Tricot G; Broxmeyer HE
    J Immunol; 1989 Jul; 143(1):140-6. PubMed ID: 2471733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granulocyte-macrophage colony-stimulating factor augments phagocytosis of Mycobacterium avium complex by human immunodeficiency virus type 1-infected monocytes/macrophages in vitro and in vivo.
    Kedzierska K; Mak J; Mijch A; Cooke I; Rainbird M; Roberts S; Paukovics G; Jolley D; Lopez A; Crowe SM
    J Infect Dis; 2000 Jan; 181(1):390-4. PubMed ID: 10608795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of human monocyte susceptibility to lymphokine-activated killer cell lysis by granulocyte-macrophage colony-stimulating factor.
    Blanchard DK; Serbousek D; Djeu JY
    Cancer Res; 1989 Sep; 49(18):5037-43. PubMed ID: 2670200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term culture of human bone marrow macrophages: macrophage development is associated with the production of granulomonopoietic enhancing activity (GM-EA).
    Wang SY; Castro-Malaspina H; Moore MA
    J Immunol; 1985 Aug; 135(2):1186-93. PubMed ID: 3891852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of cytokine messenger RNA and secretion in alveolar macrophages and blood monocytes from patients with lung cancer receiving granulocyte-macrophage colony-stimulating factor therapy.
    Thomassen MJ; Ahmad M; Barna BP; Antal J; Wiedemann HP; Meeker DP; Klein J; Bauer L; Gibson V; Andresen S
    Cancer Res; 1991 Feb; 51(3):857-62. PubMed ID: 1988125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of human monocyte tumoricidal activity by recombinant M-CSF.
    Sampson-Johannes A; Carlino JA
    J Immunol; 1988 Nov; 141(10):3680-6. PubMed ID: 3053901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage activation by granulocyte/macrophage colony-stimulating factor. Priming for enhanced release of tumor necrosis factor-alpha and prostaglandin E2.
    Heidenreich S; Gong JH; Schmidt A; Nain M; Gemsa D
    J Immunol; 1989 Aug; 143(4):1198-205. PubMed ID: 2473121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of in vivo administration of GM-CSF and G-CSF on monocyte cytotoxicity.
    Wiltschke C; Krainer M; Wagner A; Linkesch W; Zielinski CC
    Exp Hematol; 1995 May; 23(5):402-6. PubMed ID: 7536681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
    Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
    Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro induction of inhibitory macrophage differentiation by granulocyte-macrophage colony-stimulating factor, stem cell factor and interferon-gamma from lineage phenotypes-negative c-kit-positive murine hematopoietic progenitor cells.
    Ferret-Bernard S; Saï P; Bach JM
    Immunol Lett; 2004 Feb; 91(2-3):221-7. PubMed ID: 15019293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of tumor-derived cytokines on the immune system of mice bearing a mammary adenocarcinoma. II. Down-regulation of macrophage-mediated cytotoxicity by tumor-derived granulocyte-macrophage colony-stimulating factor.
    Sotomayor EM; Fu YX; Lopez-Cepero M; Herbert L; Jimenez JJ; Albarracin C; Lopez DM
    J Immunol; 1991 Oct; 147(8):2816-23. PubMed ID: 1918995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human blood-derived macrophages: differentiation in vitro of a large quantity of cells in serum-free medium.
    Vincent F; Eischen A; Bergerat JP; Faradji A; Bohbot A; Oberling F
    Exp Hematol; 1992 Jan; 20(1):17-23. PubMed ID: 1577091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.